In its review, Topline Securities commented that the local bourse experienced a volatile session, attempting to recover from the previous day's sharp sell-off. The index initially showed strength and ...

Cassava Sciences (SAVA) shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Topline data indicate ...

Intravitreal UBX1325 helped patients with diabetic macular edema gain vision but failed to meet its primary analysis endpoint in the ASPIRE clinical trial, according to a press release from Unity ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

Morgan Stanley has initiated coverage on U.S. packaged food industry stocks with a cautionary but in-line outlook, according ...

Congressional Republicans returning to Washington on Monday will tackle their toughest test yet, negotiating a massive tax ...

Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside ...

American Superconductor Corporation's improving fundamentals might not justify its high valuation. Learn more about AMSC ...

Alto Neuroscience, Inc. (NYSE: ANRO) reported financial results for the full year ending December 31, 2024, highlighting ...

"I would argue the folks closer to the operational side know better than we do, and I want to make sure that it's not all ...

NEW HAVEN, Conn. and NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical ...